accountJohn LaMattina takes on Marcia Angell and her recent interview. It sounds like he made it farther into the podcast than...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
PHARMACEUTICAL APPROVALS
Pharmaceuticals approvals are the last step in a long process of government testing. This topic tracks the approval of prescription and over-the-counter pharmaceuticals.
Pharmaceutical Approvals is part of Business Exchange, suggested by
Evan Rappaport.
This topic contains
1,743 news
and
329 blog
items.
Read updated news, blogs, and resources about Pharmaceutical Approvals. Find user-submitted articles and reactions on Pharmaceutical Approvals from
like-minded professionals.
Blogs
Recent blog posts on this topic.
I'm a bit baffled by Eli Lilly's strategy on Alzheimer's. Not the scientific side of it - they're going strongly after...
Steve Usdin at BioCentury has a very interesting article (free access) following up on that surprise decision that the...
Steve Usdin at BioCentury has a very interesting article (free access) following up on that surprise decision that the...
If you'd like to see how thoroughly a drug market can be screwed up, have a look at Greece. They're leading the way...
If you'd like to see how thoroughly a drug market can be screwed up, have a look at Greece. They're leading the way...
There's a new paper out that does something unique: it compares the screening libraries of two large drug companies,...
There's a new paper out that does something unique: it compares the screening libraries of two large drug companies,...
You'll have seen the headlines about off-label promotion of drugs by pharma companies. No, not the ones that decry it...
I have tried to listen to this podcast with Marcia Angell, on drug companies and their research, but I cannot seem to...
I have tried to listen to this podcast with Marcia Angell, on drug companies and their research, but I cannot seem to...
A few years ago, I asked the readership for the best books on the practice of medicinal chemistry and drug discovery...
There's a paper out in Drug Discovery Today with the title "Is Poor Research the Cause of Declining Productivity...
There's a paper out in Drug Discovery Today with the title "Is Poor Research the Cause of Declining Productivity...
I can't even count the number of e-mails I've gotten over the last few years asking about TauRx and their Alzheimer's...
BioCentury has an interesting piece this week on the growing budget impasse and its implications for both academic and...
Solanezumab is a story that won't go away. Eli Lilly's antibody therapy for Alzheimer's is the subject of a lot of...
Solanezumab is a story that won't go away. Eli Lilly's antibody therapy for Alzheimer's is the subject of a lot of...
One of the questions I get asked most often, by people outside of the drug industry, is whether generic medications...
Texas put up a lot of money a few years ago for cancer research. "A lot", in this case, means three billion,...
Texas put up a lot of money a few years ago for cancer research. "A lot", in this case, means three billion,...
Here's a look at something that doesn't make many headlines: the apparent failure of an entire class of potential drugs.
Here's a look at something that doesn't make many headlines: the apparent failure of an entire class of potential drugs.
Now, here's a big idea. Thirty billion dollars worth of big idea. Andrew Lo, professor of finance at MIT (Sloan) and...
Now, here's a big idea. Thirty billion dollars worth of big idea. Andrew Lo, professor of finance at MIT (Sloan) and...
Top Sources: Pharmaceutical Approvals
- SeekingAlpha.com: Home Page
- DODTracker.com New Deals Feed
- stockerblog.blogspot.com
- What's New at CBER
- RSS from PharmiWeb.com
- futurebiopharma.blogspot.com
- In the Pipeline
- FDA Law Blog
- Health News from Medical News Today
- Medical Device Recalls since November 11, 2009
Post a Job
Jobs in this Topic
Reg Affairs Approval Associate/Sr. Associate
Novartis Pharmaceuticals
|
East Hanover, NJ
Posted: Jun 12
Publications Manager - Pharmaceuticals (copy 5)
Global Pharmaceutical Company
|
St Louis, MO
Posted: Jun 17
Associate Director/Director, Regulatory Affairs (Post-Approval)
Amicus Therapeutics
|
Cranbury, NJ
Posted: Jun 12
